ArticleAsian Pacific journal of cancer prevention : APJCP2023

Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.

Kazem Anvari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.